RGF
UTHR icon

Retirement Guys Formula’s United Therapeutics UTHR Stock Holding History

Retirement Guys Formula’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
459
-5
-1% -$2.82K 0.09% 142
2026
Q1 		$275K Sell
464
-34
-7% -$16.9K 0.13% 116
2025
Q4 		$243K Sell
498
-112
-18% -$52.2K 0.11% 124
2025
Q3 		$256K Buy
+610
New +$205K 0.09% 138

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Retirement Guys Formula's UTHR Position: Q2 2026 in Review

Retirement Guys Formula reduced its United Therapeutics (UTHR) stake by 1.1% in Q2 2026, selling an estimated $2.82K and leaving 459 shares worth $249K. The position accounts for 0.09% of the portfolio, ranked #142.

Retirement Guys Formula first reported a position in UTHR in Q3 2025 and has held it in 4 quarters since. The position peaked at $275K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Retirement Guys Formula held 459 shares of United Therapeutics worth $249K as of Q2 2026.
  • Retirement Guys Formula sold 5 United Therapeutics shares in Q2 2026, an estimated $2.82K.
  • United Therapeutics made up 0.09% of Retirement Guys Formula's portfolio in Q2 2026, its #142 holding.
  • Retirement Guys Formula first reported a position in United Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Retirement Guys Formula's United Therapeutics position peaked at $275K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Retirement Guys Formula's 13F filing for Q2 2026, filed 30 Jul 2026.